These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 479764)

  • 1. Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.
    Polley MJ; Nachman RL
    J Exp Med; 1979 Sep; 150(3):633-45. PubMed ID: 479764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human complement system in thrombin-mediated platelet function.
    Polley MJ; Nachman R
    J Exp Med; 1978 Jun; 147(6):1713-26. PubMed ID: 681879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human complement in the arachidonic acid transformation pathway in platelets.
    Polley MJ; Nachman RL; Weksler BB
    J Exp Med; 1981 Feb; 153(2):257-68. PubMed ID: 7241047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of the terminal complement proteins, C5-C9, by human platelets.
    Houle JJ; Leddy JP; Rosenfeld SI
    Clin Immunol Immunopathol; 1989 Mar; 50(3):385-93. PubMed ID: 2917425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    Joiner KA; Hammer CH; Brown EJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of glycoprotein IIb-IIIa receptor function studied with platelets permeabilized by the pore-forming complement proteins C5b-9.
    Shattil SJ; Cunningham M; Wiedmer T; Zhao J; Sims PJ; Brass LF
    J Biol Chem; 1992 Sep; 267(26):18424-31. PubMed ID: 1326524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor.
    Miyama A; Kato T; Minoda I; Ueda T; Kashiba S
    Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
    Zimmerman TS; Kolb WP
    J Clin Invest; 1976 Jan; 57(1):203-11. PubMed ID: 812888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a two-domain structure of the terminal membrane C5b-9 complex of human complement.
    Bhakdi S; Tranum-Jensen J
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5872-6. PubMed ID: 293689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary C5 deficiency in man. III. Studies of hemostasis and platelet responses to zymosan.
    Breckenridge RT; Rosenfeld SI; Graff KS; Leddy JP
    J Immunol; 1977 Jan; 118(1):12-6. PubMed ID: 830743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A; Robson CA
    J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
    Joiner K; Brown E; Hammer C; Warren K; Frank M
    J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL; Kolb WP; Sodetz JM
    J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional C8 associated with human platelets.
    Tedesco F; Densen P; Villa MA; Presani G; Roncelli L; Rosso di san Secondo VE
    Clin Exp Immunol; 1986 Nov; 66(2):472-80. PubMed ID: 3815901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.
    Hammer CH; Nicholson A; Mayer MM
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5076-80. PubMed ID: 1061092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clq inhibition of the interaction of collagen with human platelets.
    Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
    J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK; Johnson RC; Dalmasso AP
    J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.